Nuzenio

Stock Titan Transcode

Stock Titan Transcode entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 7 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Major holder converts preferred shares at Transcode Therapeutics, Inc. (RNAZ) - Stock TitanStock Titan · Wed, 05 Aug 2026 20:06:30 GMTTranscode Therapeutics (RNAZ) major holders disclose convertible preferred stake - Stock TitanStock Titan · Wed, 05 Aug 2026 20:06:02 GMTDEFJ lifts TransCode Therapeutics (RNAZ) stake to 83.9% after conversions - Stock TitanStock Titan · Mon, 03 Aug 2026 20:39:36 GMTTransCode Therapeutics (RNAZ) investor discloses 6.17% stake in Schedule 13G - Stock TitanStock Titan · Tue, 28 Jul 2026 23:51:24 GMTTransCode Therapeutics (RNAZ) investor discloses 5.16% stake in common stock - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTUnleash Immuno Oncolytics (RNAZ holder) reports 9.94% TransCode Therapeutics stake - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTTransCode Therapeutics (RNAZ) holder moves toward controlling stake via conversions - Stock TitanStock Titan · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Wed, 05 Aug 2026 20:06:30 GMTMajor holder converts preferred shares at Transcode Therapeutics, Inc. (RNAZ) - Stock Titan
Wed, 05 Aug 2026 20:06:02 GMTTranscode Therapeutics (RNAZ) major holders disclose convertible preferred stake - Stock Titan
Mon, 03 Aug 2026 20:39:36 GMTDEFJ lifts TransCode Therapeutics (RNAZ) stake to 83.9% after conversions - Stock Titan
Tue, 28 Jul 2026 23:51:24 GMTTransCode Therapeutics (RNAZ) investor discloses 6.17% stake in Schedule 13G - Stock Titan
Tue, 28 Jul 2026 07:00:00 GMTTransCode Therapeutics (RNAZ) investor discloses 5.16% stake in common stock - Stock Titan
Tue, 28 Jul 2026 07:00:00 GMTUnleash Immuno Oncolytics (RNAZ holder) reports 9.94% TransCode Therapeutics stake - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Stock Titan Transcode.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.